BOLT
NASDAQ
$4.48
Bolt Biotherapeutics Inc (BOLT)
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $41 (+815.18%)
Market Cap
$8.09M
P/B Ratio
0.40
Revenue 5Y CAGR
+121.10%
Beta (5Y)
0.86
Price Chart
Valuation
Market Cap$8.09M
P/S1.25
P/B0.40
Profitability
Total Revenue (TTM)$6.50M
Gross Profit (TTM)-$17M
EBITDA-$31M
Operating Margin-29235%
EPS-$15.40
Growth & Risk
EPS 5Y CAGR-16.86%
Revenue 5Y CAGR+121.10%
FCF 5Y CAGR-9.57%
Beta (5Y)0.86
Sharpe Ratio-0.03